Insights › Market reaction

Why Biohaven (BHVN) Stock Rose 9.33% in 10 Minutes on Oct 22, 2026

1.12 million shares changed hands in those 10 minutes.

Published in ET: Feed time in ET: Approval BHVN +9.33% in 10 min after the headline
  • BHVN rose 9.33% in the 10 minutes after the 07:05:11 ET headline, from $14.25 to $15.58.
  • The headline crossed in pre-market trading, 2 hours 25 minutes before the 9:30 ET open.
  • Next earnings report on the calendar: Monday, November 9, 2026.
BHVN Why Biohaven (BHVN) Stock Rose 9.33% in 10 Minutes on Oct 22, 2026
MoveSurge publish 07:05:11 ET
MoveSurge publish
07:05:11 ET
16.32 14.75 13.13 11.56 15.75 07:03 07:05 07:25
Real 1-minute OHLC candles around publish time. Chart times are New York ET; validated market data captured by MoveSurge.

Reaction by asset (real prices)

Asset2m beforeAt release+1m+10m+1m %+10m %
BHVN 14.25 14.25 14.30 15.58 +0.35% +9.33%

Biohaven (BHVN) shares rose 9.33% in the 10 minutes after this headline reached the MoveSurge news feed at 07:05:11 ET on Thursday, October 22, 2026: “FDA accepts Biohaven’s resubmitted Vyglxia application for spinocerebellar ataxia”

BHVN in the first 10 minutes

From a reference price of $14.25 just before the headline, the stock was up 0.35% after one minute and up 9.33%, at $15.58, after 10 minutes. The first minute was nearly flat; the move came after it. 1.12 million shares changed hands in those 10 minutes. The headline crossed in pre-market trading, 2 hours 25 minutes before the 9:30 ET open.

Other BHVN headlines on October 22, 2026

  • 09:42 ET: “FDA accepts Biohaven’s resubmitted application for a brain disorder drug” (-2.11% in 10 minutes)

Biohaven at a glance

SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
Market value$1.77 billion (as of Oct 23, 2026)
Next earnings report on the calendarMonday, November 9, 2026

Prices are closes of 1-minute bars. Each move on this page is measured from the last completed bar before its headline.

What headline moved Biohaven stock on October 22, 2026?

At 07:05:11 ET, this headline crossed: “FDA accepts Biohaven’s resubmitted Vyglxia application for spinocerebellar ataxia”. The stock rose 9.33% in the next 10 minutes.

How far did BHVN move after the headline?

From $14.25 just before the headline to $15.58 10 minutes later, a +9.33% move.

When does Biohaven report earnings next?

The next report on the MoveSurge earnings calendar is Monday, November 9, 2026.

Sources

Never miss the next market-moving story

Follow the core market-moving feed across equities, macro, currencies and commodities. Your subscription includes price moves after the news, search, watchlists, alerts and research tools.

Create free accountGo real time Watch live headlines -- free
See live news
The next market-moving story will not wait

See the important story while it still matters.

Seven market specialists bring experience dating back to 2006. MoveSurge adds the speed, coverage, and clear format built for today’s market.

Core market coverageEquities, macro, currencies and commodities Clear in secondsThe story, source, context, and measured move together Built on evidenceReal headlines, timestamps, prices, and trusted sources
Go real time View the live feed Subscription renews automatically. Cancel before renewal. Information only—no trade calls.